{"product_id":"regulatory-processes-for-rare-disease-drugs-in-the-united-states-and-european-union","title":"Regulatory Processes for Rare Disease Drugs in the United States and European Union","description":"\u003ch1\u003e\u003cspan style=\"color: #262626;\"\u003eRegulatory Processes for Rare Disease Drugs in the United States and European Union\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cspan style=\"color: #262626;\"\u003eRare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe. Congress called on the U.S. Food and Drug Administration (FDA) to sponsor a National Academies study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. The resulting report provides recommendations for enhancing and promoting rare disease drug development by improving engagement with people affected by a rare disease, advancing regulatory science, and fostering collaboration between FDA and the European Medicines Agency.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #262626;\"\u003e\u003cbr\u003e\u003cstrong\u003eAutor:\u003c\/strong\u003e\u003cbr\u003e AA. VV.\u003cspan style=\"color: #b3b3b3;\"\u003e\u003cem\u003e)\u003c\/em\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003e\u003cspan style=\"color: #262626;\"\u003e\u003cstrong\u003eCaracterísticas técnicas:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan style=\"color: #262626;\"\u003eTamaño cerrado 152 x 229 mm\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan style=\"color: #262626;\"\u003e386 páginas interiores\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan style=\"color: #262626;\"\u003eTapa rústica\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan style=\"color: #262626;\"\u003eEncuadernación lomo cuadrado\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e\u003cspan style=\"color: #262626;\"\u003e\u003cspan style=\"color: #262626;\"\u003eEn Webook cuidamos el medio ambiente, imprimimos lo justo y este libro lo haremos especialmente para ti \u003cmeta charset=\"utf-8\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Bibliomanager","offers":[{"title":"Default Title","offer_id":46777594085513,"sku":"001-0000294445","price":53000.0,"currency_code":"CLP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0688\/5703\/6937\/files\/1502681_IMAGEN_TAPA_G_001.jpg?v=1779276128","url":"https:\/\/webook.cl\/products\/regulatory-processes-for-rare-disease-drugs-in-the-united-states-and-european-union","provider":"WeBook","version":"1.0","type":"link"}